Eni SpA
E
53.96
-0.59
-1.08%
Eni SpA
US · E
#283 by market cap
Listed 1970
53.96
-0.59
-1.08%
Live - 5344 symbols - heartbeat 10s ago
· 2026-10-08 07:00
Pre-market
55.22
+2.33%
After-hours
53.50
-0.85%
- Market cap
- 77.27B
- P/E (TTM)i
- 14.34
- P/Bi
- 1.33
- EPSi
- 1.75
- Div yieldi
- 4.45%
- 52W posi
- 87%
Reader sentiment
Are you bullish or bearish on E?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.73, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -7.48% YoY
Margins
- Gross margin
- 9.43%
- Operating margin
- 5.49%
- Net margin
- 2.92%
Key ratios & quality
- Enterprise valuei
- 91.94B
- Altman Z-Scorei
- 1.73
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 75.82B | 69.88B | 43.99B | 76.58B | 132.51B | 93.72B | 88.80B | 82.15B |
| Gross profit | 13.21B | 10.90B | 3.13B | 13.96B | 22.78B | 12.40B | 10.08B | 7.75B |
| Selling & admin expenses | 3.09B | 3.00B | 2.86B | 2.89B | 3.02B | 3.14B | 3.26B | 3.23B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 9.70B | 7.47B | 43.00M | 10.80B | 19.81B | 9.02B | 6.65B | 4.51B |
| Pretax profit | 10.11B | 5.75B | -5.98B | 10.69B | 22.05B | 10.23B | 6.49B | 5.78B |
| Tax | 5.97B | 5.59B | 2.65B | 4.85B | 8.09B | 5.37B | 3.73B | 3.02B |
| Net profit | 4.14B | 155.00M | -8.63B | 5.84B | 13.96B | 4.86B | 2.76B | 2.76B |
| Basic EPS | 2 | 0 | -5 | 3 | 8 | 3 | 2 | 2 |
| Diluted EPS | 2.30 | 0.08 | -4.84 | 3.20 | 7.90 | 2.80 | 1.56 | 1.56 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 19.19B | 17.22B | 20.55B | 19.52B | 20.06B | 22.67B |
| Gross profit | 1.12B | 1.10B | 1.85B | 1.12B | 2.00B | 2.81B |
| Selling & admin expenses | 801.00M | 753.00M | 744.00M | 791.00M | 823.00M | 759.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 595.00M | 507.00M | 1.19B | -199.00M | 629.00M | 2.60B |
| Pretax profit | 710.00M | 787.00M | 1.65B | 298.00M | 830.00M | 3.98B |
| Tax | 1.22B | 832.00M | 780.00M | 161.00M | 805.00M | 1.31B |
| Net profit | 1.20B | 561.00M | 865.00M | 137.00M | 1.28B | 3.38B |
| Basic EPS | 1 | 0 | 1 | 0 | 1 | 2 |
| Diluted EPS | 0.72 | 0.32 | 0.48 | 0.02 | 0.68 | 2.16 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 39.75B | 34.93B | 32.90B | 57.88B | 61.86B | 49.31B | 44.00B | 48.87B |
| Cash & ST investments | 17.69B | 12.56B | 14.72B | 14.44B | 18.31B | 16.77B | 14.93B | 15.09B |
| Inventory | 4.65B | 4.73B | 3.89B | 6.07B | 7.71B | 6.19B | 6.26B | 5.14B |
| Total assets | 118.37B | 123.44B | 109.65B | 137.77B | 152.13B | 142.61B | 146.94B | 137.07B |
| Total current liabilities | 28.44B | 29.64B | 24.09B | 44.00B | 49.53B | 38.61B | 38.68B | 36.82B |
| Short-term debt | 5.78B | 6.50B | 5.64B | 5.03B | 8.43B | 8.14B | 10.10B | 9.63B |
| Long-term debt | 20.08B | 18.91B | 21.90B | 23.71B | 19.37B | 21.72B | 21.57B | 20.14B |
| Total liabilities | 67,300,000,000.00 | 75,540,000,000.00 | 72,155,000,000.00 | 93,246,000,000.00 | 96,900,000,000.00 | 88,962,000,000.00 | 91,291,000,000.00 | 84,282,000,000.00 |
| Total equity | 51.07B | 47.90B | 37.49B | 44.52B | 55.23B | 53.64B | 55.65B | 52.79B |
| Retained earnings | 40.83B | 36.04B | 25.41B | 28.57B | 37.34B | 37.76B | 35.18B | 35.82B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 46.44B | 43.73B | 41.38B | 48.87B | 68.10B | 61.70B |
| Cash & ST investments | 16.75B | 16.02B | 16.30B | 15.09B | 19.97B | 15.09B |
| Inventory | 5.63B | 5.80B | 6.26B | 5.14B | 5.40B | 6.41B |
| Total assets | 144.46B | 136.21B | 134.99B | 137.07B | 147.71B | 147.01B |
| Total current liabilities | 37.30B | 34.86B | 34.27B | 36.82B | 46.27B | 41.70B |
| Short-term debt | 10.74B | 10.43B | 10.55B | 9.63B | 10.36B | 8.81B |
| Long-term debt | 20.13B | 19.86B | 19.66B | 20.14B | 21.74B | 23.83B |
| Total liabilities | 87,188,000,000.00 | 82,805,000,000.00 | 82,020,000,000.00 | 84,282,000,000.00 | 93,415,000,000.00 | 90,075,000,000.00 |
| Total equity | 57.27B | 53.41B | 52.97B | 52.79B | 54.29B | 56.93B |
| Retained earnings | 37.29B | 37.15B | 36.62B | 35.82B | 35.80B | 37.75B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 13.65B | 12.39B | 4.82B | 12.86B | 17.46B | 15.12B | 13.09B | 13.33B |
| Depreciation & amortization | 6.99B | 8.11B | 7.30B | 7.06B | 7.21B | 7.48B | 7.60B | 7.35B |
| Free cash flow | 4.53B | 4.02B | 178.00M | 7.63B | 9.40B | 5.90B | 4.60B | 4.10B |
| Dividends paid | -2.95B | -3.02B | -1.97B | -2.36B | -3.01B | -3.05B | -3.07B | -3.08B |
| Stock buybacks / issuance | -- | -400.00M | -- | -400.00M | -2.40B | -1.80B | -2.01B | -1.90B |
| Ending cash balance | 10.86B | 5.99B | 9.41B | 8.27B | 10.18B | 10.21B | 8.18B | 8.42B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.39B | 3.52B | 3.08B | 4.35B | 1.43B | 4.27B |
| Depreciation & amortization | 1.77B | 1.82B | 1.84B | 1.81B | 1.62B | 1.78B |
| Free cash flow | 566.00M | 1.37B | 900.00M | 1.26B | -1.01B | 2.06B |
| Dividends paid | -765.00M | -759.00M | -781.00M | -775.00M | -766.00M | -786.00M |
| Stock buybacks / issuance | -386.00M | -280.00M | -560.00M | -670.00M | -289.00M | -560.00M |
| Ending cash balance | 9.15B | 9.17B | 8.95B | 8.42B | 8.92B | 8.56B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.33 | 0.30 | -20.26 | 13.99 | 27.78 | 8.65 | 4.76 | 4.77 |
| ROA %i | 3.54 | 0.12 | -7.41 | 4.63 | 9.51 | 3.17 | 1.74 | 1.69 |
| ROIC %i | 6.22 | 1.16 | -10.26 | 8.32 | 17.46 | 5.98 | 3.94 | 3.66 |
| 5-year avg ROE %i | -0.07 | -0.44 | -1.54 | 1.80 | 6.02 | 6.09 | 6.99 | 11.99 |
| EBIT margin %i | 19.48 | 14.06 | -2.32 | 19.46 | 23.68 | 19.57 | 17.42 | 16.98 |
| FCF / sales %i | 5.97 | 5.75 | 0.40 | 9.96 | 7.09 | 6.30 | 5.18 | 4.99 |
| Current ratioi | 1.40 | 1.18 | 1.37 | 1.32 | 1.25 | 1.28 | 1.14 | 1.33 |
| Quick ratioi | 1.14 | 0.90 | 1.09 | 0.77 | 0.82 | 0.90 | 0.87 | 0.87 |
| Debt / assetsi | 21.85 | 24.44 | 28.91 | 24.05 | 20.95 | 23.89 | 25.07 | 24.95 |
| LT debt / equityi | 39.36 | 49.48 | 69.66 | 63.24 | 42.81 | 48.74 | 50.67 | 51.26 |
| Interest coveragei | 3.17 | 2.41 | -0.21 | 3.53 | 3.36 | 2.26 | 1.72 | 1.71 |
| Revenue CAGR (3Y) %i | 1.60 | 7.81 | -13.05 | 0.33 | 23.77 | 28.68 | 5.06 | -14.73 |
| Net income CAGR (3Y) %i | -- | -- | -- | 12.16 | 354.41 | -- | -23.32 | -42.73 |
| FCF CAGR (3Y) %i | 135.43 | -- | -50.14 | 18.97 | 32.78 | 221.30 | -15.49 | -24.16 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 4.61 | 4.43 | 5.28 | 4.77 | 4.48 | 9.95 |
| ROA %i | 1.71 | 1.63 | 1.93 | 1.69 | 1.58 | 3.57 |
| ROIC %i | 3.70 | 3.58 | 4.02 | 3.66 | 3.43 | 6.67 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.91 | 19.75 | 18.79 | 16.98 | 15.95 | 17.23 |
| FCF / sales %i | 5.88 | 4.70 | 4.62 | 4.99 | 3.05 | 3.64 |
| Current ratioi | 1.25 | 1.25 | 1.21 | 1.33 | 1.47 | 1.48 |
| Quick ratioi | 0.92 | 0.90 | 0.86 | 0.87 | 0.76 | 0.82 |
| Debt / assetsi | 24.79 | 25.60 | 25.69 | 24.95 | 24.76 | 25.16 |
| LT debt / equityi | 46.81 | 49.14 | 49.00 | 51.26 | 53.27 | 54.20 |
| Interest coveragei | 1.64 | 1.49 | 1.53 | 1.71 | 1.80 | 2.48 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Exploration & Production is the largest reported line at 61.31% of revenue, across 7 reported segments.
- Enilive follows at 23.27%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Exploration & Production61.31%
Enilive23.27%
Refining and chemicals22.13%
Global Gas & Liquefied natural gas (LNG) Portfolio (GGP) and Power20.84%
Plenitude12.38%
Corporate and other activities0.32%
Region
Italy34.87%
Other European Union19.45%
Rest of Europe18.10%
Asia11.78%
Africa8.19%
Americas7.57%
Quote time 2026-10-08 07:00:07 · For reference only, not investment advice and not tailored to your situation.